Certified by Founder
Lodge
Inspire Biotherapeutics Inc
start up
Canada
- Toronto, Ontario
- 17/03/2023
- Pre-Seed
- Undisclosed Amount
Inspire has developed a lung tropic AAV gene therapy platform that has demonstrated transduction and long-term expression in lung tissue without impact on other tissue types in disease-relevant animal models. We are currently pursing initiation of a Proof-of-Concept clinical trial for a lethal neonatal lung disease with short time to data readout and success of therapy. The platform can then be applied to Cystic Fibrosis and other monogenic lung diseases.
- Industry Biotechnology Research
- Website https://www.inspirebiotx.com/
- LinkedIn https://www.linkedin.com/company/inspire-biotherapeutics-inc/people/
Related People
Sandra DonaldsonFounder
Canada -
Toronto, Ontario
VP & COO OIRM. CEO & COO, Inspire Biotherapeutics. Experienced executive with a demonstrated history of nurturing research networks into thriving ecosystems while working in biotechnology and clinical trial sectors.
Datatruck | $12,000,000 | (Jan 29, 2026)
Vention | $110,000,000 | (Jan 29, 2026)
Tenbin Labs | $7,000,000 | (Jan 29, 2026)
Oro(US) | $3,000,000 | (Jan 29, 2026)
Yolando | $8,500,000 | (Jan 29, 2026)
Origin(US) | Undisclosed Amount | (Jan 29, 2026)
Gyde | $60,000,000 | (Jan 29, 2026)
Limy AI | $10,000,000 | (Jan 29, 2026)
Scholé AI | $3,000,000 | (Jan 29, 2026)
Emobi | $3,400,000 | (Jan 29, 2026)
Adaptive6 | $28,000,000 | (Jan 29, 2026)
Fiddler AI | $30,000,000 | (Jan 28, 2026)